Bank Julius Baer & Co. Ltd Zurich Has $39,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Bank Julius Baer & Co. Ltd Zurich lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 98.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 118 shares of the company's stock after selling 8,009 shares during the period. Bank Julius Baer & Co. Ltd Zurich's holdings in HCA Healthcare were worth $39,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the third quarter worth approximately $39,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $31,000. Activest Wealth Management grew its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares during the period. Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after acquiring an additional 50 shares during the period. Finally, Eastern Bank acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $62,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA opened at $323.33 on Wednesday. The firm has a market cap of $79.60 billion, a PE ratio of 14.72, a PEG ratio of 1.10 and a beta of 1.68. The stock's fifty day moving average price is $317.93 and its two-hundred day moving average price is $346.50. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm earned $5.90 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.89%. HCA Healthcare's payout ratio is 13.11%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HCA. Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. Royal Bank of Canada dropped their target price on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. Barclays dropped their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Bank of America dropped their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Finally, Raymond James lowered HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.